2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

The purpose of the Seminar was to discuss in a highly multidisciplinary environment the relative role of obesity, OSAS or both in the pathogenesis of dyslipidemia, a well-known risk factor for cardiovascular disease. The topic is currently debated in the literature and has important therapeutic implications, given the controversial results of OSAS treatment on metabolic variables and the recent progress in the therapeutic approach to the obese patient. The Seminar could help increase the cooperation in research between the fields of obesity and OSAS in Europe.

2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Introduction and epidemiology of dyslipidemia in OSAS patients

M. Bonsignore (Palermo, Italy)

Slides

Accompanying documents

Data from animal models: role of IH and obesity

V. Polotsky (Baltimore, United States of America)

Slides

Accompanying documents

Visceral adipose tissue as a target for therapeutic intervention: an update

F. Giorgino (Bari, Italy)

Slides

Accompanying documents

Effects of OSA on metabolic dysfunction in children

L. Kheirandish-Gozal (Chicago, USA)

Slides

Accompanying documents

Effects of OSA on metabolic dysfunction in adolescents - is OSA relevant for adolescent obesity?

S. Verhulst (Wilrijk, Belgium)

Slides

Accompanying documents

Does sleep loss play a role in adipose tissue dysfunction?

C. Philipps (Sydney, Australia)

Accompanying documents

Inflammation in obese adipose tissue

S. Sasson (Jerusalem, Israel)

Slides

Accompanying documents

Genetic factors: OSAS, obesity or both?

R. L. Riha (Edinburgh, United Kingdom), T. Gislason (Reykjavik, Iceland)

Slides

Accompanying documents

CPAP treatment: effects on plasma lipids and liver function

V. Polotsky (Baltimore, MD, USA)

Slides

Accompanying documents

2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

#{title}